MX2021005755A - Composiciones para el tratamiento de enfermedades de la piel y envejecimiento de la piel asociados al estres oxidativo y diagnostico de enfermedades de la piel asociadas con estres oxidativo. - Google Patents
Composiciones para el tratamiento de enfermedades de la piel y envejecimiento de la piel asociados al estres oxidativo y diagnostico de enfermedades de la piel asociadas con estres oxidativo.Info
- Publication number
- MX2021005755A MX2021005755A MX2021005755A MX2021005755A MX2021005755A MX 2021005755 A MX2021005755 A MX 2021005755A MX 2021005755 A MX2021005755 A MX 2021005755A MX 2021005755 A MX2021005755 A MX 2021005755A MX 2021005755 A MX2021005755 A MX 2021005755A
- Authority
- MX
- Mexico
- Prior art keywords
- oxidative stress
- roxp
- compositions
- skin diseases
- skin
- Prior art date
Links
- 230000036542 oxidative stress Effects 0.000 title abstract 4
- 208000017520 skin disease Diseases 0.000 title abstract 4
- 239000000203 mixture Substances 0.000 title abstract 3
- 230000032683 aging Effects 0.000 title abstract 2
- 238000003745 diagnosis Methods 0.000 title 1
- 241000186427 Cutibacterium acnes Species 0.000 abstract 4
- 230000003248 secreting effect Effects 0.000 abstract 2
- 102000004020 Oxygenases Human genes 0.000 abstract 1
- 108090000417 Oxygenases Proteins 0.000 abstract 1
- 239000012634 fragment Substances 0.000 abstract 1
- 229940055019 propionibacterium acne Drugs 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/164—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
- A61K38/44—Oxidoreductases (1)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/02—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
- A61K8/66—Enzymes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/99—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from microorganisms other than algae or fungi, e.g. protozoa or bacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/18—Antioxidants, e.g. antiradicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/08—Anti-ageing preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q5/00—Preparations for care of the hair
- A61Q5/006—Antidandruff preparations
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/02—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving viable microorganisms
- C12Q1/04—Determining presence or kind of microorganism; Use of selective media for testing antibiotics or bacteriocides; Compositions containing a chemical indicator therefor
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/26—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving oxidoreductase
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
- G01N33/5044—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics involving specific cell types
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/20—Dermatological disorders
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/70—Mechanisms involved in disease identification
- G01N2800/7004—Stress
- G01N2800/7009—Oxidative stress
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Immunology (AREA)
- Pharmacology & Pharmacy (AREA)
- Molecular Biology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Biomedical Technology (AREA)
- Dermatology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Birds (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Cell Biology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Tropical Medicine & Parasitology (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Pathology (AREA)
- General Physics & Mathematics (AREA)
- Food Science & Technology (AREA)
- Toxicology (AREA)
- Gerontology & Geriatric Medicine (AREA)
- Gastroenterology & Hepatology (AREA)
- Mycology (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP18206646 | 2018-11-16 | ||
| PCT/EP2019/081546 WO2020099663A1 (en) | 2018-11-16 | 2019-11-15 | Compositions for treating oxidative stress-associated skin diseases and skin ageing and diagnosis of oxidative stress-associated skin diseases |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MX2021005755A true MX2021005755A (es) | 2021-08-11 |
Family
ID=64331864
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2021005755A MX2021005755A (es) | 2018-11-16 | 2019-11-15 | Composiciones para el tratamiento de enfermedades de la piel y envejecimiento de la piel asociados al estres oxidativo y diagnostico de enfermedades de la piel asociadas con estres oxidativo. |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US20220000762A1 (https=) |
| EP (1) | EP3880304B8 (https=) |
| JP (1) | JP7532361B2 (https=) |
| KR (1) | KR102913696B1 (https=) |
| CN (1) | CN113038959B (https=) |
| AU (1) | AU2019380669B2 (https=) |
| BR (1) | BR112021008496A2 (https=) |
| CA (1) | CA3118524A1 (https=) |
| ES (1) | ES2994459T3 (https=) |
| MX (1) | MX2021005755A (https=) |
| PL (1) | PL3880304T3 (https=) |
| WO (1) | WO2020099663A1 (https=) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES3025685T3 (en) | 2014-06-17 | 2025-06-09 | Crown Laboratories Inc | Genetically modified bacteria and methods for genetic modification of bacteria |
| EP3285872A4 (en) | 2015-04-20 | 2019-02-20 | S-Biomedic NV | METHOD AND COMPOSITIONS FOR CHANGING THE COMPOSITION OF SKIN MICROBIOMA WITH COMPLEX MIXTURES OF BACTERIAL BARS |
| WO2017147507A1 (en) | 2016-02-24 | 2017-08-31 | Xycrobe Therapeutics, Inc. | Skin probiotic formulation |
| KR102584057B1 (ko) | 2016-10-19 | 2023-09-27 | 에스-바이오메딕 엔브이 | 박테리아 균주의 복합 혼합물을 사용하여 피부 마이크로바이옴의 조성을 변경하기 위한 방법 및 조성물 |
| CA3183350A1 (en) | 2020-06-23 | 2021-12-30 | Thomas M. Hitchcock | Probiotic skin formulations |
| CN116940330A (zh) * | 2020-12-21 | 2023-10-24 | 南洋理工大学 | 短链脂肪酸作为去屑剂的用途 |
| CN113219097B (zh) * | 2021-01-15 | 2022-06-24 | 杭州海关技术中心 | 婴幼儿配方奶粉中肉碱对映体拆分和测定方法 |
| CA3239122A1 (en) * | 2021-12-17 | 2023-06-22 | S-Biomedic | A freeze-dried composition and preparation thereof |
| EP4197523A1 (en) * | 2021-12-17 | 2023-06-21 | DSM IP Assets B.V. | A freeze-dried composition and preparation thereof |
| KR20240135644A (ko) * | 2022-01-12 | 2024-09-11 | 에스-바이오메딕 엔브이 | 스킨 케어 조성물 및 이의 용도 |
| CN115165819B (zh) * | 2022-05-27 | 2024-08-09 | 天津科技大学 | 一种快速定量分析芦丁的荧光分子印迹光子晶体凝胶条的制备方法及应用 |
| CN120173837B (zh) * | 2025-05-21 | 2025-12-05 | 杭州微致生物科技有限公司 | 痤疮丙酸杆菌vb208基因编辑方法及其应用 |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4816567A (en) | 1983-04-08 | 1989-03-28 | Genentech, Inc. | Recombinant immunoglobin preparations |
| US5270163A (en) | 1990-06-11 | 1993-12-14 | University Research Corporation | Methods for identifying nucleic acid ligands |
| JP2011037764A (ja) * | 2009-08-11 | 2011-02-24 | Shiseido Co Ltd | 皮膚外用剤、美白剤、抗酸化剤および抗老化剤 |
| FR2954140A1 (fr) * | 2009-12-17 | 2011-06-24 | Oreal | Compositions cosmetiques ou dermatologiques a base de bacteriocines et de prebiotiques |
| ITPR20110035A1 (it) | 2011-05-06 | 2012-11-07 | Bormioli Rocco & Figlio Spa | Capsula. |
| CN104364394B (zh) * | 2012-03-17 | 2019-02-22 | 加州大学评议会 | 痤疮的快速诊断和个体化治疗 |
| ITUA20162141A1 (it) | 2016-03-31 | 2017-10-01 | Bormioli Pharma Spa | Capsula di chiusura |
| IT201600097495A1 (it) | 2016-09-28 | 2018-03-28 | Bormioli Pharma S R L | Capsula con struttura di contenimento e rilascio di un prodotto |
| KR102584057B1 (ko) | 2016-10-19 | 2023-09-27 | 에스-바이오메딕 엔브이 | 박테리아 균주의 복합 혼합물을 사용하여 피부 마이크로바이옴의 조성을 변경하기 위한 방법 및 조성물 |
-
2019
- 2019-11-15 AU AU2019380669A patent/AU2019380669B2/en active Active
- 2019-11-15 JP JP2021526737A patent/JP7532361B2/ja active Active
- 2019-11-15 EP EP19800907.8A patent/EP3880304B8/en active Active
- 2019-11-15 KR KR1020217018454A patent/KR102913696B1/ko active Active
- 2019-11-15 BR BR112021008496-7A patent/BR112021008496A2/pt unknown
- 2019-11-15 CN CN201980075535.6A patent/CN113038959B/zh active Active
- 2019-11-15 CA CA3118524A patent/CA3118524A1/en active Pending
- 2019-11-15 MX MX2021005755A patent/MX2021005755A/es unknown
- 2019-11-15 PL PL19800907.8T patent/PL3880304T3/pl unknown
- 2019-11-15 US US17/293,464 patent/US20220000762A1/en active Pending
- 2019-11-15 ES ES19800907T patent/ES2994459T3/es active Active
- 2019-11-15 WO PCT/EP2019/081546 patent/WO2020099663A1/en not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| EP3880304B8 (en) | 2024-11-20 |
| EP3880304A1 (en) | 2021-09-22 |
| KR102913696B1 (ko) | 2026-01-16 |
| AU2019380669B2 (en) | 2025-01-30 |
| EP3880304C0 (en) | 2024-10-16 |
| WO2020099663A1 (en) | 2020-05-22 |
| KR20210094576A (ko) | 2021-07-29 |
| PL3880304T3 (pl) | 2025-03-03 |
| US20220000762A1 (en) | 2022-01-06 |
| EP3880304B1 (en) | 2024-10-16 |
| JP2022507616A (ja) | 2022-01-18 |
| CA3118524A1 (en) | 2020-05-22 |
| BR112021008496A2 (pt) | 2021-08-10 |
| CN113038959B (zh) | 2024-09-13 |
| JP7532361B2 (ja) | 2024-08-13 |
| CN113038959A (zh) | 2021-06-25 |
| AU2019380669A1 (en) | 2021-05-20 |
| ES2994459T3 (en) | 2025-01-24 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MX2021005755A (es) | Composiciones para el tratamiento de enfermedades de la piel y envejecimiento de la piel asociados al estres oxidativo y diagnostico de enfermedades de la piel asociadas con estres oxidativo. | |
| PH12020551038A1 (en) | Compositions comprising co-selected microbiota and methods for use thereof | |
| MX2025000166A (es) | Un esteroide de c21-pirazolilo disustituido con 19-nor c3,3 y metodos de uso del mismo | |
| MX2022004051A (es) | Composicion novedosa para el cuidado de la piel. | |
| SA521421559B1 (ar) | أجهزة قابلة للزرع للعلاج بالخلايا وطرق ذات الصلة | |
| PH12017501217A1 (en) | Methods of treating retinal diseases | |
| MX2013014437A (es) | Metodos y composiciones para predecir la actividad del modulador de receptor x de retinoide. | |
| EA201490512A1 (ru) | Композиции, содержащие культивируемую в анаэробных условиях микробиоту кишечника человека | |
| WO2016201450A3 (en) | Cancer treatment and diagnosis | |
| PH12018500762A1 (en) | Ppar agonists, compounds, pharmaceutical compositions, and methods of use thereof | |
| MX2023005014A (es) | Metodos de tratamiento de enfermedades inflamatorias cronicas. | |
| MX2021009247A (es) | Metodos, sistemas y kits para tratar enfermedades inflamatorias que se dirigen a il18r1. | |
| MX2022004052A (es) | Composicion novedosa para el cuidado de la piel. | |
| MX2022004056A (es) | Composicion novedosa para el cuidado de la piel. | |
| MX2017004662A (es) | Composiciones y metodos para mejorar la movilidad o actividad o tratar la fragilidad. | |
| PH12017501304A1 (en) | Levodopa and carbidopa intestinal gel and method of use | |
| PH12020551912A1 (en) | Use for preventing and treating myeloid-derived suppressor cell-related diseases | |
| MX2024010539A (es) | Metodos para tratar enfermedades asociadas con ciliopatias. | |
| JP2015500820A (ja) | Ｅｇｆｒ阻害の有害反応を予防または処置するための組成物 | |
| WO2017011356A3 (en) | Mcj inhibitors for use in treating drug-induced diseases and conditions | |
| MX2020010243A (es) | Composiciones bucales y metodos para animales. | |
| MX2022004050A (es) | Composicion novedosa para el cuidado de la piel. | |
| MX2022004055A (es) | Composicion novedosa para el cuidado de la piel. | |
| EA202091653A1 (ru) | Миноциклин для лечения воспалительных заболеваний кожи | |
| WO2016066722A3 (en) | Bacteriophage combinations for human or animal therapy |